欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2094/001
药品名称
Duofen
活性成分
ibuprofen 3.0 mg/ml
paracetamol 10.0 mg/ml
剂型
Solution for infusion
上市许可持有人
Vale Pharmaceuticals Limited, Ireland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Ireland (IE)
Portugal (PT)
Greece (GR)
Poland (PL)
许可日期
2021/05/26
最近更新日期
2023/01/13
药物ATC编码
N02BE51 paracetamol, combinations excl. psycholeptics
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/2094/001_Final PL
Date of last change:2021/07/01
Final SPC
|
SE/H/2094/001_Final SPC
Date of last change:2021/07/01
PAR
|
Duofen solution for infusion
PAR Summary
|
Duofen solution for infusion ENG sPAR
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase